Clinical Trial

SPO2 VALIDATION STUDY - PHILIPS FAST 2025

Completed
View on ClinicalTrials.gov →
Summary
Clinical investigation is to validate the SpO2 accuracy of the M1133AX5, M1133AX6, and AlarX4 (nasal ala application) SpO2 sensors under test with the Philips FAST Pulse Oximetry technology.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-24; most recent amendment 2026-03-31.
Status change: Recruiting → Completed 2026-03-31
Status change: Not Yet Recruiting → Recruiting 2025-12-04
Trial Details
NCT Number NCT07221526
Lead Sponsor Philips Clinical & Medical Affairs Global
Conditions PULSE OXIMETRY
Enrollment 86 participants
Start Date 2025-10-28
Primary Completion 2026-02-05 (estimated)
Study Completion 2026-02-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-01